XYLEM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.4 USD | +1.37% |
|
+3.57% | +15.77% |
| Apr. 26 | Wolfe Adjusts Price Target on Xylem to $145 From $143 | MT |
| Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 14,188 | 18,346 | 21,625 | 19,927 | 27,570 | 32,010 | - | - |
| Enterprise Value (EV) 1 | 15,780 | 19,555 | 22,716 | 20,863 | 28,835 | 32,713 | 32,115 | 31,345 |
| P/E ratio | 35.7 x | 72.7 x | 51 x | 56.4 x | 41 x | 39.3 x | 33.3 x | 28.4 x |
| Yield | 1.22% | 1.02% | 0.93% | 1.09% | 1.15% | 1.09% | 1.16% | 1.2% |
| Capitalization / Revenue | 2.7 x | 3.76 x | 4.16 x | 3.61 x | 3.74 x | 3.76 x | 3.57 x | 3.38 x |
| EV / Revenue | 3.01 x | 4.01 x | 4.37 x | 3.78 x | 3.92 x | 3.85 x | 3.58 x | 3.31 x |
| EV / EBITDA | 16 x | 25.2 x | 26.5 x | 23 x | 20.7 x | 19.3 x | 17.2 x | 15.5 x |
| EV / FCF | 25.7 x | 30.5 x | 68.8 x | 53.8 x | 48.1 x | 32.9 x | 29.4 x | 25.7 x |
| FCF Yield | 3.88% | 3.28% | 1.45% | 1.86% | 2.08% | 3.04% | 3.4% | 3.9% |
| Price to Book | 4.8 x | 6.19 x | 6.72 x | 5.7 x | 2.72 x | 3 x | 2.83 x | 2.66 x |
| Nbr of stocks (in thousands) | 180,079 | 180,232 | 180,325 | 180,222 | 241,078 | 241,770 | - | - |
| Reference price 2 | 78.79 | 101.8 | 119.9 | 110.6 | 114.4 | 132.4 | 132.4 | 132.4 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/3/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,249 | 4,876 | 5,195 | 5,522 | 7,364 | 8,505 | 8,967 | 9,482 |
| EBITDA 1 | 984 | 776 | 856 | 908 | 1,392 | 1,691 | 1,864 | 2,026 |
| EBIT 1 | 727 | 525 | 611 | 672 | 1,072 | 1,333 | 1,498 | 1,659 |
| Operating Margin | 13.85% | 10.77% | 11.76% | 12.17% | 14.56% | 15.67% | 16.71% | 17.49% |
| Earnings before Tax (EBT) 1 | 416 | 285 | 511 | 440 | 635 | 1,031 | 1,254 | 1,405 |
| Net income 1 | 401 | 254 | 427 | 355 | 609 | 822.8 | 984.7 | 1,114 |
| Net margin | 7.64% | 5.21% | 8.22% | 6.43% | 8.27% | 9.67% | 10.98% | 11.75% |
| EPS 2 | 2.210 | 1.400 | 2.350 | 1.960 | 2.790 | 3.366 | 3.981 | 4.657 |
| Free Cash Flow 1 | 613 | 641 | 330 | 388 | 599 | 994.4 | 1,091 | 1,221 |
| FCF margin | 11.68% | 13.15% | 6.35% | 7.03% | 8.13% | 11.69% | 12.16% | 12.88% |
| FCF Conversion (EBITDA) | 62.3% | 82.6% | 38.55% | 42.73% | 43.03% | 58.8% | 58.53% | 60.26% |
| FCF Conversion (Net income) | 152.87% | 252.36% | 77.28% | 109.3% | 98.36% | 120.85% | 110.77% | 109.57% |
| Dividend per Share 2 | 0.9600 | 1.040 | 1.120 | 1.200 | 1.320 | 1.439 | 1.536 | 1.593 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/3/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,265 | 1,323 | 1,272 | 1,364 | 1,380 | 1,506 | 1,448 | 1,722 | 2,076 | 2,118 | 1,996 | 2,108 | 2,176 | 2,226 | 2,093 |
| EBITDA 1 | 217 | 206 | 174 | 215 | 245 | 274 | 236 | 329 | 411 | 416 | 366.8 | 431.3 | 451.7 | 462.9 | 417.4 |
| EBIT 1 | 155 | 147 | 116 | 155 | 187 | 214 | 167 | 259 | 315 | 313 | 272.1 | 334.8 | 358.8 | 368 | 307.8 |
| Operating Margin | 12.25% | 11.11% | 9.12% | 11.36% | 13.55% | 14.21% | 11.53% | 15.04% | 15.17% | 14.78% | 13.63% | 15.88% | 16.49% | 16.53% | 14.71% |
| Earnings before Tax (EBT) 1 | 133 | 126 | 98 | 136 | 17 | 189 | 126 | 114 | 185 | 210 | 204.4 | 242.1 | 250.6 | 273 | - |
| Net income 1 | 114 | 113 | 82 | 112 | 12 | 149 | 99 | 92 | 152 | 266 | 162.8 | 198.2 | 214.8 | 229.8 | 187.4 |
| Net margin | 9.01% | 8.54% | 6.45% | 8.21% | 0.87% | 9.89% | 6.84% | 5.34% | 7.32% | 12.56% | 8.15% | 9.4% | 9.87% | 10.32% | 8.95% |
| EPS 2 | 0.6300 | 0.6200 | 0.4500 | 0.6200 | 0.0700 | 0.8200 | 0.5400 | 0.4500 | 0.6300 | 1.100 | 0.6640 | 0.8206 | 0.8844 | 0.9438 | 0.8217 |
| Dividend per Share 2 | 0.2800 | 0.2800 | 0.3000 | 0.3000 | 0.3000 | 0.3000 | 0.3300 | 0.3300 | - | 0.3300 | 0.3600 | 0.3600 | 0.3600 | 0.3600 | - |
| Announcement Date | 11/2/21 | 2/3/22 | 5/4/22 | 8/2/22 | 11/1/22 | 2/7/23 | 5/4/23 | 8/2/23 | 10/31/23 | 2/6/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,592 | 1,209 | 1,091 | 936 | 1,265 | 703 | 105 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | 665 |
| Leverage (Debt/EBITDA) | 1.618 x | 1.558 x | 1.275 x | 1.031 x | 0.9088 x | 0.4155 x | 0.0562 x | - |
| Free Cash Flow 1 | 613 | 641 | 330 | 388 | 599 | 994 | 1,091 | 1,221 |
| ROE (net income / shareholders' equity) | 19.1% | 8.57% | 13.8% | 15.4% | 12.1% | 9.04% | 9.82% | 9.99% |
| ROA (Net income/ Total Assets) | 7.33% | 3.09% | 5.02% | 4.38% | 5.06% | 4.79% | 5.77% | 6.4% |
| Assets 1 | 5,473 | 8,230 | 8,513 | 8,114 | 12,032 | 17,187 | 17,057 | 17,410 |
| Book Value Per Share 2 | 16.40 | 16.50 | 17.80 | 19.40 | 42.10 | 44.20 | 46.80 | 49.80 |
| Cash Flow per Share 2 | 4.630 | 4.550 | 2.960 | 3.290 | 3.840 | 5.680 | 6.380 | 7.030 |
| Capex 1 | 226 | 183 | 208 | 208 | 271 | 391 | 395 | 398 |
| Capex / Sales | 4.31% | 3.75% | 4% | 3.77% | 3.68% | 4.6% | 4.4% | 4.2% |
| Announcement Date | 2/6/20 | 2/4/21 | 2/3/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
132.4
USD
Average target price
136.7
USD
Spread / Average Target
+3.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.77% | 32.01B | |
| +11.73% | 82.35B | |
| +20.17% | 71.09B | |
| +20.89% | 37.72B | |
| +9.19% | 27.2B | |
| +3.18% | 26.74B | |
| +4.22% | 26B | |
| +16.93% | 25.5B | |
| +17.14% | 24.76B | |
| +17.30% | 17.84B |
- Stock Market
- Equities
- XYL Stock
- Financials Xylem Inc.
